Arthur J. Gallagher

AJG · NYSE

$259.26+$6.25 (+2.47%)TodayMarket closed · Oct 20, 7:45 PM ET

Prev close $253.01

AJG analyst rating

BuyConsensus of 17 analysts over the last 12 months. 82% rate it a buy.

Strong buy0
Buy14
Hold3
Underperform0
Sell0

12-month price target · 21 analysts

Average $296.29 (+14.3% upside)

Low: $252.50
Now: $259.26
High: $407.40

Upgrades and downgrades

The latest rating actions, newest first

AJG analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Wells Fargo	Oct 12, 2026	Maintains	Overweight	$291.00 → $284.00	60%
Mizuho	Oct 7, 2026	Maintains	Outperform	$292.00 → $271.00	58%
Cantor Fitzgerald	Oct 7, 2026	Maintains	Neutral	$300.00 → $280.00	62%
Morgan Stanley	Oct 6, 2026	Maintains	Overweight	$285.00 → $260.00	49%
Morgan Stanley	Sep 25, 2026	Maintains	Overweight	$290.00 → $285.00	49%
RBC Capital	Sep 24, 2026	Maintains	Outperform	$310.00 → $290.00	44%
Wells Fargo	Sep 24, 2026	Maintains	Overweight	$296.00 → $291.00	60%
Mizuho	Sep 16, 2026	Maintains	Outperform	$300.00 → $292.00	58%
Morgan Stanley	Aug 19, 2026	Maintains	Overweight	$270.00 → $290.00	49%
Argus Research	Aug 17, 2026	Maintains	Buy	$267.00 → $300.00	59%

The case for and against

Updated Sep 26, 2026

Bull case

Arthur J. Gallagher is a leading insurance brokerage firm with a strong track record of organic growth and strategic acquisitions, making it a long-term growth stock with potential for margin expansion. However, there are risks associated with key person dependence, regulatory compliance, and execution of M&A deals. Overall, the company's diverse workforce and board, along with its disciplined approach to pricing and margin expansion, make it an attractive investment option in the insurance brokerage industry.

Bear case

Arthur J. Gallagher is a longstanding and internationally recognized insurance brokerage and risk management firm, with a diverse portfolio and a significant global presence. However, with potential headwinds in the P&C markets and ongoing M&A activity, there is a risk of margin contraction and slower growth, potentially hindering share performance in the short term. While the company's guidance remains strong, it may be prudent to closely monitor any potential challenges in the market and execution of strategic initiatives.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.